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Triacylglycerollglycerol to energy provision in the hypertrophied heart, mediated through
lipoprotein lipase (LPL) is largely unknown and the contribution of very-low-density lipoprotein (VLDL)
receptor to control of LPL presentation at the endothelium is unclear. For isolated perfused rat hearts, cold
acclimation (CA) induced volume-overload hypertrophy, with decreased developed pressure (Pb0.01),
increased end-diastolic volume of the left ventricle (Pb0.001) and a loss of contractile reserve in response to
dobutamine challenge (Pb0.01). Oleate utilisation by perfused hearts was unchanged by CA, however uptake
of intralipid emulsion increased 3-fold (Pb0.01). CA increased the proportion of lipid deposited in tissue
lipids from 10% in euthermic controls to 40% (Pb0.01) although the overall contribution of individual lipid
classes was unaffected. Cold acclimation signiﬁcantly increased heparin-releasable LPL (Pb0.05) and tissue
residual LPL (Pb0.01). Western blot analysis indicated preserved expression of proteins coding for SERCA2,
muscle-CPT1 and VLDL-receptor following CA, while AMPKα2 and phospho-AMPKα2 were unaffected. These
observations indicate that for physiological hypertrophy AMPK phosphorylation does not mediate the
enhanced translocation of LPL to cardiac endothelium.
© 2008 Elsevier B.V. Open access under CC BY-NC-ND license.1. IntroductionThe heart has a high and unremitting demand for energy and relies
on metabolic ﬂexibility to derive this energy from the prevailing
substrates present in plasma [1]. In the fed (postprandial) state the
majority of energy is derived from lipids in the diet. These are
principally transported in the form of chylomicrons and must be
assimilated into the myocardium through lipoprotein lipase, an
endothelium-expressed enzyme that controls the transport of
triacylglycerol-derived fatty acids (FA) into the cardiomyocyte across
the endothelium. Chylomicrons may provide the majority of FA-der-
ived energy as measured for the in vitro perfused myocardium [2] and
in the whole animal [3]. Moreover, given that mammals are
predominantly in the ‘postprandial state’ chylomicrons may be the
primary fuel for the heart. Interestingly, LPL is not synthesised in the
endothelium but is derived from the cardiomyocyte itself [4] andmust
be translocated across the interstitial space to be re-expressed on the
luminal surface of the capillary endothelium [5].
LPL is intricately coupled to the very-low-density lipoprotein
receptor (VLDL-receptor) and investigations have demonstrated the
potency of the VLDL-receptor to bind lipoproteins and act as an anchor
[6], facilitating the lipolysis of lipoprotein particles to release NEFA
and thus generating a high local concentration at the endothelium.
The VLDL-receptor may also facilitate uptake of core lipids from+44 0121 4146919.
-NC-ND license.lipoproteins [7]. Further studies have also demonstrated the ability of
VLDL-receptor to bind LPL directly, and elegant experiments have
proposed the exploitation of this mechanism for the translocation and
subsequent re-expression of LPL from the cardiomyocyte, across the
endothelium to the luminal surface of capillaries [8]. More recent
investigations noted the expression of VLDL-receptor protein may also
be coupled to cellular energy status through activation of AMPK [9].
While the control of cardiac expression of LPL remains contro-
versial, the involvement of the VLDL-receptor in trafﬁcking implies a
degree of control that is critically located at the capillary endothelium.
This provides a mechanism regulated by prevailing plasma substrate
concentration which may be important during hypertriacylglycerole-
mia. Indeed, given the location of LPL-synthesis within the cardio-
myocyte control of LPL expression at the mRNA level may appear
somewhat distant from the site of LPL action, namely the capillary
endothelium. An important recent observation suggests that activa-
tion of adenosine monophosphate-activated protein kinase (AMPK) in
the cardiomyocyte by chemical activators (AICAR) led to increased
endothelial expression of LPL [10]. However, this appears at odds with
the importance of AMPK in the signalling of low energy status in
tissues, typically seen after ischaemia-reperfusion injury [11]. Under
metabolic conditions where oxygen is limiting for the production of
ATP through oxidative phosphorylation the teleological rationale for
increasing FA uptake into tissue that cannot utilise this substrate
efﬁciently is unclear, particularly given the adverse consequences of
myocardial TAG accumulation [12]. Clearly, this has implications for
pathological cardiac hypertrophy, characterised by a decrease in
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and glycolysis for ATP synthesis in an oxygen-sparing manner.
However, no estimate of the involvement of VLDL-receptor and
AMPK is available for physiological hypertrophy.
We exploited the cold-acclimated rat as a model for physiological
cardiac hypertrophy to investigate for the ﬁrst time the inﬂuence of
hypertrophy on the expression of LPL and VLDL-receptor proteins and
quantify the metabolic contribution of triacylglycerol to energy
metabolism. In addition, the presentation of LPL at the endothelial
surface was correlated with levels of VLDL-receptor to investigate
whether control of LPL translocation may reside in the VLDL-receptor.
2. Materials and methods
2.1. Materials
3H-[9,10]-oleic acid and 3H-[9,10]-triolein were purchased from
Amersham Biosciences (Chalfont, UK). Intralipid lipid emulsion (10%
w/v triacylglycerol) was obtained from Fresenius Kabi Ltd, (Runcorn,
UK). Dobutamine was obtained from Boehringer Ingelheim,
(Bracknell, UK). Fatty acid-free bovine albumin and all buffer salts
were purchased from Sigma (Poole, UK). Antibodies to AMPKα2 and
threonine 172 phospho-AMPKα2 were obtained from Kinasource Ltd.
(Dundee, Scotland). Ventricular balloons were constructed ‘in house’
using Saran Wrap polythene ﬁlm.
2.2. Methods
2.2.1. Animal maintenance
Animals were maintained in accordance with the UK Home Ofﬁce,
Animal Scientiﬁc Procedures Act (1986) and housed at 22 °C 12 h light/
12 h dark with ad libitum access to food and water. Male Wistar rats
(60 g starting body mass) were cold acclimated as previously
described [13,14]. Brieﬂy, rats were housed in an environmental
chamber and exposed to 22 °C 12 h light/12 h dark. Over the
subsequent 4 week period the temperature and light period duration
were gradually decreased until at 4 weeks the rats were exposed to 1 h
light/23 h dark and environmental temperature 4 °C. Throughout this
period animals had ad libitum access to both food and water. Control
animals were purchased at the appropriate experimental body mass
(250–300 g).
2.2.2. Radio-isotope tracer preparation
Oleic acid (ﬁnal concentration 0.4 mM) was pre-bound to fatty
acid-free bovine albumin as previously described [2]. Brieﬂy, oleic acid
sodium salt was dissolved in pre-warmed saline and added to bovine
albumin (2.0 g, to give a ﬁnal concentration in perfusate 2.0%w/v). 3H-Table 1
Cardiac performance in vivo for control and cold-acclimated hearts and the effects of dobutam
hearts
Control
Untreated +Do
Heart rate (in vivo — bpm) 430±37
Mean arterial pressure (mmHg) 106±12
RPP (mmHg/min) 30962±5685
Cardiac mass (wet mass — g) 1.51±0.13
Estimated EDV (μl) 313±24
Cardiac TAG (μmol/g) 4.82±1.75
Heart rate (bpm) 292.4±39.7 29
Peak systolic pressure (mmHg) 106.8±12.9 1
Developed pressure (mmHg) 90.5±11.4 1
+dP/dt (mmHg/s) 1682.5±130.5 240
−dP/dt (mmHg/s) −1288.8±94.1 −187
Data represents mean±SD (n=6). Statistical signiﬁcance is measured as ANOVA with corr
++Pb0.01: the effects of dobutamine; ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.001.[9,10]-oleic acid (9.0 MBq/100 ml ﬁnal concentration) was saponiﬁed
(0.1 M KOH) and added to the oleic acid. Intralipid was pre-labelled
with 3H-[9,10]-triolein (9.0 MBq/12 mg intralipid triacylglycerol). The
intralipid mixture was homogenised (ultraturrax blade homogeniser,
full power 15 s, 4-cycles, over ice) and added to fatty acid-free bovine
albumin (ﬁnal concentration 2.0%w/v in perfusate) to give the ﬁnal
triacylglycerol working concentration (0.4 mM).
2.2.3. Tissue isolation and heart perfusion
Animals were prepared surgically as outlined previously [2].
Brieﬂy, anaesthesia was induced with pentobarbital (60 mg/kg ip in
saline) and following thoracotomy hearts excised with lungs and
thymus in situ and immersed in ice-cold Krebs–Hensleit medium.
Excess tissue was dissected away, the thymus was divided to reveal
the aortic arch and the aorta was trimmed at the level of the carotid
artery branches and cannulated (16G cannula). Hearts were perfused
in retrograde fashion as outlined previously [15,16]. Flow through the
heart was established and extra tissue was dissected away. An incision
was made in the right ventricle and the left atrial appendage was
removed. A small ﬂexible non-elastic balloonwas inserted into the left
atrium through the mitral valve and into the left ventricle. This ﬂuid-
ﬁlled balloonwas attached to a ﬁne plastic catheter and connected to a
pressure transducer (MEMSCAP, Skoppum, Norway) and a graduated
syringe (0–1000 μl: Hamilton, Nevada, USA). Hearts were maintained
at 37 °C and perfused at a constant pressure (100 cm H2O) with a
Krebs–Hensleit crystalloid medium supplemented with glucose
(10 mM) and CaCl2 (1.3 mM) gassed with oxygen/CO2 (95:5).
Developed pressure was measured following isovolumic contraction
of the ﬂuid-ﬁlled balloon and recorded to computer using a digital
interface (AD Instruments, Chalgrove, Oxford, UK).
2.2.4. Ventricular performance
The initial balloon volumewas adjusted until the diastolic pressure
recorded measured 0 mmHg and the developed pressure (difference
between systolic and diastolic pressures) was b10 mmHg. Balloon
volume was increased from this baseline, in incremental steps (50 μl)
and developed pressure was recorded in real time. Pressures were
allowed to stabilise until diastolic pressure remained constant before
initiating further increases in balloon volume. Incremental increases in
balloon volume were performed until the peak systolic pressure
developed exceeded 200 mmHg. The balloon was then deﬂated and
the process repeated. For selected experiments, the sympathomimetic
inotrope dobutaminewas added (ﬁnal concentration 300 nM) and the
preparation was allowed to stabilise for 10 min before new measure-
ments of developed pressure, heart rate and coronary ﬂow measured.
For metabolism experiments a single balloon volume was used,
corresponding to a ﬁxed end-diastolic pressure (EDP). Balloon volumeine addition (300 nM) on cardiac performance of perfused control and cold-acclimated
Cold acclimated
butamine Untreated +Dobutamine
418±45
134±9++
29305±3760
1.82±0.24++
377±15++
4.65±1.60
8.9±51.7 247.0±25.5 279.2±25.9
27.8±15.2⁎ 71.8±13.1++ 88.2±16.0++
13.7±12.6⁎⁎ 58.3±16.1++ 75.8±19.8++
9.8±139.1⁎⁎⁎ 1419.6±522.6 1723.8±454.1++
5.0±71.2⁎⁎⁎ −1133.6±415.1 −1434.8±484.7
ection for multiple comparisons and represented as: The effects of cold acclimation;
Fig. 1. Diastolic performance (A) and developed pressure (B) for Langendorff-perfused
rat hearts from control or CA-rats. Results represent mean±SD (n=6 hearts in all
groups). Statistical signiﬁcance indicated as: Effect of cold acclimation ⁎⁎Pb0.01.
Fig. 2. Inﬂuence of substrate on rate-pressure product for control and cold-acclimated
rat hearts. Results represent mean±SD (n=6 hearts in all groups). Statistical signiﬁcance
set at Pb0.05.
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designated the ‘working pressure’ of the myocardium. Coronary ﬂow
was estimated from timed collections of a known volume of perfusate
and expressed as volume/unit mass of cardiac tissue.
Ventricular performance was calculated off-line following the
experiment using computer analysis software (Chart Version 5.0, AD
Instruments, Chalgrove, Oxford, UK). Heart rate, systolic pressure,
diastolic pressure and hence developed pressure were measured. Rate
of change of pressure (+dP/dt) was calculated from themaxima of ﬁrst
order derivative of pressure trace. Rate-pressure product (RPP) was
calculated at each balloon volume as the product of heart rate
(bpm)×developed pressure (mmHg). End-diastolic volume wasestimated from the linear regression of diastolic performance curve
for values greater than zero at the point the regression line bisected
the balloon volume at diastolic pressure=zero.
2.2.5. Quantitation of plasma tritiated water
Metabolism of oleic acid and intralipid was estimated from
quantitation of tritiated water as previously described [2]. Brieﬂy,
aliquots of perfusate (1.0 ml) were extracted with chloroform:
methanol (2:1) (20 ml). Following addition of water (4.0 ml), tritiated
water was estimated in the aqueous fraction by scintillation counting.
Metabolism was calculated with reference to the speciﬁc activity at
the start of the experiment.
2.2.6. Total lipid extraction
Total cholesterol and triglycerides were also extracted from the
hearts as described previously [14]. Brieﬂy, aliquots (100 mg) of heart
powder were extracted with methanol:chloroform (1:2). Extracts
were evaporated to dryness and resuspended in absolute ethanol.
Cardiac TAG and cholesterol were measured using commercial kits.
For selected extracts, lipids were separated into phospholipids,
diacylglycerol, fatty acid, triacylglycerol and cholesterol ester as
outlined previously [2]. Brieﬂy, ethanol extracts of tissue (100 mg)
were separated on thin layer chromatography (TLC) plates (Silica Gel
60, 250 μm) and separated using the solvent system hexane:diethyl
ether:acetic acid (70/30/1.6). Lipids were visualised using rhodamine
6G and UV light. Lipids were mechanically recovered from the TLC
plate and quantiﬁed by liquid scintillation counting.
2.2.7. Lipoprotein lipase activity
Lipoprotein lipase (LPL) activity was measured as previously
described [17,2]. Brieﬂy, separate groups of hearts from control and
cold-acclimated rats were perfused with Krebs–Hensleit medium
containing glucose (10 mM) and CaCl2 (1.3 mM) as outlined above.
Perfusion was maintained initially in non-recirculating mode to wash
out erythrocytes. Recirculating perfusion was established and main-
tained for 5min, afterwhich heparin (10 U/ml ﬁnal concentration)was
added and recirculated for a further 2 min. Samples of perfusate were
isolated and frozen in liquid nitrogen. Cardiac tissue was then snap-
frozen in liquid nitrogen and cardiac mass was noted. Aliquots of post-
heparin perfusate and acetone-dried heart powders (10 mg) were
reacted with triacylglycerol emulsion (ﬁnal concentration 5.6 mM)
pre-labelled with 3H-[9,10]-triolein supplemented with human
plasma (ratio plasma to ﬁnal reaction volume 1:6) as a source of
Apolipoprotein CII. Reactions were carried out in Tris–HCl buffer
Fig. 3. Total lipid utilisation for control and cold-acclimated hearts perfused with either
oleate or intralipid. Results represent mean±SD (n=6 hearts in all groups). Statistical
signiﬁcance indicated as: Effect of perfusion with intralipid ++Pb0.01; Effect of cold
acclimation ⁎⁎Pb0.01.
Fig. 5. Fate of assimilated lipid taken up by perfused hearts after 60 min perfusion.
Control and cold-acclimated hearts were perfused with either oleate or intralipid.
Results represent mean±SD (n=6 hearts in all groups). Statistical signiﬁcance indicated
as: Effect of perfusion with intralipid ++Pb0.01; Effect of cold acclimation ⁎⁎Pb0.01.
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(ﬁnal concentration 2.0%w/v). Incubations were carried out at 37 °C
and activities were expressed per unit mass of cardiac tissue. Total
cardiac LPL activitywas estimated as the sumof tissue residual LPL and
heparin-releasable LPL activity.
2.2.8. Immunoblotting for proteins
Standard Western immunoblotting techniques were used for the
detection and estimation of relative amounts of sarcoplasmic–
endoplasmic reticulum Ca2+-ATPase (SERCA2), VLDL-receptor, muscle-
carnitine palmitoyl transferase-1 (CPT1), AMPKα2, phospho-AMPKα2
and tubulin proteins. Brieﬂy, cardiac tissue (50 mg) was powdered in
liquid nitrogen and extracted with RIPA buffer containing protease
inhibitors, followed by centrifugation (10,000 rpm for 10 min) and
recovery of the supernatant. The membranes were probed with
antibodies speciﬁc for SERCA2, VLDL-receptor, muscle-CPT1 (all Santa
Cruz — initial dilution 1:1000) AMPKα2, Threonine-172 phospho-
AMPKα2 (both Kinasource Ltd, Dundee, Scotland — initial dilution
1:1500) and mouse monoclonal anti-Tubulin (Sigma — initial dilutionFig. 4. Estimation of fatty acid β-oxidation from oleate and intralipid with time for
control or cold-acclimated rat hearts. Results represent mean±SD (n=6 hearts in all
groups). Statistical signiﬁcance set at Pb0.05.1:2500). Differing sample protein loadings were used for different
antibodies (SERCA2, Threonine-172 phospho-AMPKα2 20 μg; VLDL-
receptor, muscle-CPT1, AMPKα2 10–15 μg; Tubulin 10 μg). Densitometry
ofWesternblotswasestimatedusing ImageJ software. Proteinexpression
was corrected for the expression of an internal control (Tubulin).
2.2.9. In vitro rates of β-oxidation
Rates of β-oxidationwere estimated as outlined previously [18,14].
Peroxisomal oxidation of oleate was estimated following inhibition of
oxidative phosphorylation using rotenone, Antimycin A and potas-
sium cyanide in the reaction buffer and repeating the assay.
Mitochondrial β-oxidation activity was quantiﬁed following subtrac-
tion of the peroxisomal from total β-oxidation. Activity was normal-
ised against tissue protein determined by the BCA protein assay kit
(Sigma, Poole, UK).
2.2.10. Statistical analysis
Statistical analysis was carried out using Single Factor ANOVA
analysis with Bonferroni correction for multiple comparisons where
appropriate. Data represents mean±standard deviation.
3. Results
During cold acclimation all rats gained weight normally and
appeared to tolerate the cold exposure. Under anaesthesia, mean
arterial pressure was signiﬁcantly increased in CA-rats (Pb0.01),
whereas heart rate was unaffected by CA. At post-mortem comparison
of body mass for control and CA-rats revealed no difference in growth
despite the progressive cold stress (body mass 262±6 g control vs
276±35 g cold acclimated: n=6; NS). However for CA-rats heart mass
was signiﬁcantly increased 20% (Pb0.01: Table 1). Estimates of end-
diastolic volume indicate a statistically signiﬁcant 20% increase in
volume (Pb0.001: Table 1). Estimation of developed pressure
throughout the range of balloon volumes indicated that for CA-rats,
at peak developed pressure, measured pressures were decreased 40%
(Pb0.01; Fig. 1).
3.1. Cardiac performance
Cold acclimation led to a 30% decrease in peak systolic pressure
(Pb0.01) and a 35% decrease in developed pressure for a ﬁxed end-
diastolic pressure (Pb0.01: Table 1) compared with euthermic control
rats. Addition of dobutamine to control heart perfusions increased
peak systolic pressure 20% (Pb0.05) and developed pressure 25%
(Pb0.01: Table 1). In addition, dobutamine also induced a 40% increase
in the rate of change of pressure (measured as +dP/dt) for control
Fig. 7. Cardiac lipoprotein lipase activity for heparin-releasable, tissue residual or total
LPL. Results represent mean±SD (n=6 hearts in all groups). Statistical signiﬁcance
indicated as: Effect of cold acclimation ⁎Pb0.05, ⁎⁎Pb0.01.
622 Y. Cheng, D. Hauton / Biochimica et Biophysica Acta 1781 (2008) 618–626hearts (Pb0.001). For cold-acclimated (CA) rats dobutamine was
without effect on peak systolic pressure, developed pressure and
+dP/dt (NS: Table 1).
3.2. Rate-pressure product
Comparing RPP for control and CA-rat hearts perfused with
glucose alone, or in combinationwith oleate or intralipid the differing
substrates were without effect on cardiac performance when perfused
at ﬁxed end-diastolic pressure (Fig. 2).
3.3. Total lipid utilisation
Total utilisationwas estimated as the sumof tissue lipids remaining
and β-oxidation at 60 min. Total utilisation was preserved in CA-rat
hearts perfused with oleate-containing buffer (NS: Fig. 3). Intralipid
perfusion for control rat hearts led to a 55% decrease in total utilisation
compared with control oleate-perfused hearts (Pb0.01: Fig. 3).
However, when comparedwith CA-rats, intralipid utilisation increased
3-fold following CA (Pb0.01: Fig. 3).
3.4. β-oxidation
Oxidation of both oleate and intralipid remained linear throughout
the period of perfusion. Cold acclimation was without effect on oleate
oxidation by perfused hearts (Fig. 4). For intralipid-perfused rat hearts
rate of β-oxidation was preserved in CA hearts (Fig. 4).
3.5. Lipid fate
Fate was estimated as the proportion of total uptake represented
by tissue lipid or β-oxidation. For control hearts perfused with oleate,
β-oxidation represented 60% of total uptake, and tissue lipids
represented the remaining 40%. This proportion was preserved in
CA-rat hearts perfused with oleate (NS: Fig. 5). For intralipid-perfused
control hearts the proportion undergoing β-oxidation increased to
91.6±6.1% (Pb0.01: Fig. 5). For CA hearts perfused with intralipid
β-oxidation represented 53% of total utilisation and was signiﬁcantly
different from intralipid-perfused controls (Pb0.01: Fig. 5).
3.6. Tissue lipids
Comparison of the tissue components of labelled lipids revealed
that CA signiﬁcantly reduced the proportion of oleate deposited as
diacylglycerol (20.7±8.8% control vs 4.9±4.1% CA; Pb0.01: Fig. 6) and
non-esteriﬁed fatty acid (21.3±10.5% control vs 3.8±2.3% CA; Pb0.01:
Fig. 6). This was accompanied by a signiﬁcant, 70% greater accumula-
tion of oleate as triacylglycerol in CA-rat hearts (Pb0.05: Fig. 6).Fig. 6. Distribution of tissue lipid between different lipid classes following perfusion
with either oleate or intralipid. Results represent mean±SD (n=6 hearts in all groups).
Statistical signiﬁcance indicated as: Effect of perfusion with intralipid +Pb0.05,
++Pb0.01; Effect of cold acclimation ⁎Pb0.05, ⁎⁎Pb0.01.Perfusion of hearts with labelled intralipid resulted in a 3-fold
increase in labelled lipids deposited as cholesterol ester, comparing
oleate and intralipid-perfused hearts (Pb0.05: Fig. 6). This was
preserved for both control and CA-rat hearts (Pb0.05: Fig. 6).
Estimation of cardiac tissue unlabelled TAG concentration revealed
that CA had no effect on tissue TAG content (Table 1).
3.7. Lipoprotein lipase activity
For both control- and CA-hearts, tissue residual LPL activity was
approximately double that found for heparin-releasable LPL activity
(Fig. 7). Cold acclimation led to a 45% greater heparin-releasable LPL
activity (733±146 pmol/g/h control rat vs 1068±236 pmol/g/h CA-rat;
Pb0.05; Fig. 7). Tissue residual LPL for CA-rat hearts was 2-fold greater
than controls (Pb0.01: Fig. 7). By calculation, total cardiac LPL activity
was increased 90% for CA-rat hearts compared with corresponding
euthermic controls (Pb0.01: Fig. 7).
3.8. In vitro β-oxidation
Total β-oxidationwas unaffected following CA of rats (22.1±5.9 nmol/
mg protein/h control vs 23.6±4.5 nmol/mg protein/h CA: Fig. 8).
Following inhibition of oxidative phosphorylation, estimation of
peroxisomal β-oxidation also remained unchanged following CA
(3.48±0.58 nmol/mg protein/h control vs 3.22±0.96 nmol/mg pro-
tein/h CA: Fig. 8). Therefore by calculation, mitochondrial β-oxidation
was unchanged following CA in the heart.
3.9. Western blot analysis
Densitometric analysis of Western blots from control and
CA-hearts perfused with oleate revealed that CPT1, SERCA2 andFig. 8. Estimation of in vitro β-oxidation of oleate by homogenates of cardiac tissue
following cold acclimation. Results represent mean±SD (n=6 hearts in all groups).
Statistical signiﬁcance set at Pb0.05.
Fig. 9. Analysis of the effect of cold acclimation on protein expression by Western blot
for SERCA2, CPT1 and VLDL-receptor proteins. (A) Representative western blots from
cardiac tissue homogenates. (B) Densitometric analysis of Western blots for estimation
of expression of different proteins. Results represent mean±SD (n=6 hearts in all
groups). Statistical signiﬁcance set at Pb0.05.
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Investigation of the effect of perfusion substrate (oleate or intralipid)
on protein expression revealed that neither oleate (Fig. 10A) nor
intralipid (Fig. 10B) affected the expression of AMPKα2 protein or
phospho-AMPKα2 protein during the course of the perfusion in either
control or CA-rat hearts.Fig. 10. Analysis of the effect of perfusion substrate on protein expression by Western
Representative western blots from cardiac tissue perfused with oleate. (B) Representative
Western blots carried out for estimation of expression of different proteins. Results represe4. Discussion
We document for the ﬁrst time that increases in LPL activity
associated with physiological hypertrophy are not connected with
changes to VLDL-receptor, one proposed mechanism for the translo-
cation of LPL to the cardiac endothelium. Cold acclimation (CA)
produced a model of volume-overload hypertrophy characterised by
an enlarged heart, increased end-diastolic volume and preserved
expression of both SERCA2a and muscle-CPT1 (m-CPT1). This is
analogous to other forms of physiological hypertrophy including
pregnancy [19] and exercise [20]. Moreover, previous investigations of
cold acclimation also describe volume-overload hypertrophy with
elevated systolic blood pressure [21], a preserved capillary density
[22] and oxygen delivery [23]. CA was chosen over other forms of
physiological hypertrophy to overcome the variability in different
levels of exercise stress and the degree of hypertrophy induced [24] or
the inﬂuence of phases of pregnancy on myocardial LPL activity [25].
We postulate that the acclimation phase delivers a steadily increasing
challenge to energy demands in the rat. Rats defend core temperature
and achieve this through increased activity, thermogenesis and
hyperphagia accompanied with changes to blood ﬂow distribution
[26]. We demonstrate relatively preserved absolute myocardial
performance, yet when corrected for tissue mass cardiac performance
appears poor. Dobutamine challenge reveals a loss of contractile
reserve in CA hearts. It is unclear whether this reﬂects an absolute loss
of β-adrenoceptors, hence desensitisation, or a loss of the ability to
increase contractility [27,28]. Previous studies with cold acclimation
noted enhanced catecholamine release [29] coupled with increased
diurnal activity, and raised heart rate [30,31] suggesting similarities
with low intensity exercise. It may thus be anticipated the loss of
contractile reserve reﬂects desensitisation and down-regulation of
β-adrenoceptors following catecholamine exposure.
Our experiment documents an increased tissue LPL activity
following CA as both increased heparin-releasable LPL (functionalblot for VLDL-receptor, AMPKα2 and threonine 172 phospho-AMPKα2 proteins. (A)
western blots from cardiac tissue perfused with intralipid. Densitometric analysis of
nt mean±SD (n=6 hearts in all groups). Statistical signiﬁcance set at Pb0.05.
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previously for cardiac muscle following CA [32,33]. By contrast,
exercise was without effect on myocardial LPL protein content [34]
and pregnancy led to decreased myocardial LPL activity [35]. What
is not clear is the stimulus for increased LPL translocation to the
endothelial surface following CA. Our hypothesis detailing enhanced
VLDL-receptor expression necessary for the improved translocation
of LPL to the endothelium is not proven. Indeed it is conceivable
that if VLDL-receptor represents a ‘transport mechanism’ for LPL
then it may not necessarily be functional at maximum capacity,
however this study was not designed to test such redundancy. Other
models have shown a direct correlation between VLDL-receptor
expression and heparin-releasable LPL for muscle and adipose tissue
as a result of glomerulosclerosis [36], showing a negative correlation
between these two proteins and plasma triacylglycerol concentra-
tion. By contrast, sepsis led to decreased cardiomyocyte VLDL-
receptor expression [37] yet earlier experiments document
increased cardiac LPL resulting from sepsis [38]. Clearly, the
coupling of VLDL-receptor with LPL is neither direct nor straightfor-
ward. It was also noted that the rate of β-oxidation for intralipid is
linear for the duration of the experiment, suggestive for LPL
retention at the endothelium [39].
Our data reveals that control of LPL activity is probably multi-
factorial. Indeed, we conﬁrm that cold acclimation increased cardiac
LPL activity, but this was not mediated through changes to AMPK/
p-AMPK. Oxidative phosphorylation was thus sufﬁcient to meet the
metabolic demands of the heart for both normal and hypertrophied
hearts suggesting that under these perfusion conditions AMPK does
not control translocation of LPL to the heparin-releasable compart-
ment. Few studies describe physiological changes to AMPK activity,
indeed neither chronic calorie restriction nor overnight fasting altered
cardiac AMPK activity in mice [40], conditions previously noted to
increase cardiac heparin-releasable LPL [41]. Previous investigations
exploiting pressure-overload hypertrophy document increased
p-AMPK levels for hearts perfused with palmitate, while supplemen-
tationwith octanoate restored levels to normal, improvingmechanical
performance [42]. Our experiments were of sufﬁcient duration to
observe changes to the translocation rate of LPL to the endothelium,
should perfusion conditions have had an acute effect on cardiac LPL
activity [43].
Of interest is the observation that for both control and CA hearts
β-oxidation of FA derived from oleate or intralipid remains constant,
this was further supported by the in vitro estimate of β-oxidation
capacity and the analysis of m-CPT1 protein expression. This is
crucial to our interpretations, as previous experiments exploiting
more severe models of volume-overload hypertrophy document
changes to m-CPT1 activity accompanied by preserved mitochondrial
function [44]. We are therefore conﬁdent that for these experimental
conditions we provide adequate lipids to fuel oxidation. The
estimates for uptake and β-oxidation of lipid substrates documented
here are in accordance with data collected previously for perfused
working hearts [2,45]. Interestingly, the enhanced uptake of intra-
lipid as a result of increased heparin-releasable LPL for CA hearts
appears ‘channelled’ towards storage, supporting the importance for
fuelling muscle contraction ﬁrst whereas biosynthetic processes are
of secondary importance [7]. The increase in the proportion of
intralipid β-oxidised in control hearts, compared with oleate most
likely reﬂects the slow rate of lipolysis and then transfer of intralipid-
derived FA across the endothelium. This may result from the hetero-
geneity in intralipid emulsion particle sizes or the absence of
apolipoprotein-assisted binding. The increased heparin-releasable
LPL activity described for CA-hearts restored the relative proportions
of intralipid oxidised and deposited as tissue lipids to levels similar
to oleate implying that uptake (and hence delivery to the
cardiomyocyte) is the rate-limiting step and that oxidative phos-
phorylation the primary sink for lipids. The increased lipid deposi-tion into all lipid classes following CA supports the predominance of
acyl-CoA synthetase 1 (ACS1) in cardiac tissue [46] but may also
indicate the increased activity of glycerol phosphate acyl transferase
(GPAT) enzyme in the mitochondria, a control point dividing lipid
between energy provision and storage of glycerolipids [47] and
increased activity of GPAT was previously described for the rat
following CA [48]. This lipid accumulation may also be a protective
mechanism to limit fatty acid-induced apoptosis – lipotoxicity – in
the myocardium [49]. We cannot comment directly on the utilisation
of endogenous sources of triacylglycerol during this experiment,
however we have previously shown that myocardial deposits of tri-
acylglycerol are small [14] and we note that CA did not alter myo-
cardial unlabelled TAG content. Previous experiments detail a rapidly
cycling small intracellular pool of triacylglycerol for cardiomyocytes
that FAs are diverted into before partition between β-oxidation and
tissue lipids [50].
The use of intralipid emulsions rather than chylomicrons may
appear controversial due to the heterogeneity of lipid particle size and
the absence of apolipoproteins E and CII (Apo E and ApoCII). However,
previous experiments have documented the clearance of protein-free
lipid emulsions from the plasma of rats [51]. Moreover, this was
inhibited by Triton WR1339 and protamine sulphate — both treat-
ments documented to decrease the activity of LPL [52]. In addition,
particle number rather than particle size was more important for the
clearance of intralipid in vivo [53]. More recent experiments describe
the efﬁcient clearance of intralipid from plasma from mice
(T1/2=2.5 min); chemical inhibition of LPL decreased intralipid
clearance by perfused hearts 82% [3]. Perfusion of mouse hearts in
the absence of ApoE and ApoCII yielded LPL-dependent uptake of
intralipid emulsions [54]. Intralipid increased cardiac lipid content in a
dose-dependent manner and increased LPL translocation across the
cardiac endothelium [39]. Therefore we are conﬁdent that for the
investigation of LPL activity in situ undertaken here the use of
intralipid emulsions is valid.
The choice of Langendorff perfusion over the working heart
preparation was made in order to normalise the workloads placed
on the perfused hearts. Given that hypertrophy of myocardium results
from increased wall stress in the ventricle and is a compensatory
mechanism to decrease this [55], we were unable to make accurate
predictions of the afterload (‘work’) with which to challenge the
hearts. The assumption was therefore made to use a ﬁxed measured
end-diastolic pressure and hence normalise thewall tension in control
and CA hearts.
LPL activity was measured in separate groups of tissues to those
used for metabolic investigations as we have previously shown that
the composition of the perfusion medium will alter the presentation
of LPL at the endothelial surface. Indeed, perfusionwith triacylglycerol
increased heparin-releasable LPL activity [2]. A potential shortcoming
for our protocol may involve the measurement of ‘active’ LPL enzyme
only. Early investigations outline a post-translational regulation for
LPL activity in the hearts following fasting and refeeding [56]. Neither
levels of mRNA nor protein coding for LPL were altered following
fasting. The recent observation that over-expression of angiopoietin-
like protein 4 (Angptl4) inhibited cardiac LPL and decreased intralipid
utilisation by perfused hearts [57], coupled with the conversion of
active LPL dimers into inactivemonomers by Angptl4 in adipose tissue
[58], demonstrates a further level of complexity for LPL regulation. The
characterisation of a transcription-dependent mechanism for mo-
dulating LPL activity in the heart through conversion of active dimeric
LPL to inactive monomers [59] suggests the involvement of an
Angplt4-like protein. Our protocol only measures the active compo-
nent of LPL secreted, therefore translocation of LPL may be continuous
and the acute control of LPL activity may reside in an Angplt4-like
mechanism. The experimental protocol remains valid, however, as the
critical component is lipid substrate delivered to the myocardium
rather than estimates of total enzyme released.
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Cold acclimation results in a physiological hypertrophy that is
characterised by preserved energetics and normal phosphorylation
status for AMPK. Abundant chylomicrons that result fromhyperphagia
will provide an increasing contribution to substrate utilisation for the
myocardium via enhanced LPL protein levels but this was not
mediated through anticipated changes to either AMPK or the VLDL-
receptor. It is unclear whether the activation of AMPK that results
from pathological forms of hypertrophy [42] will trigger enhanced
LPL translocation to the capillary endothelium [10]. In addition,
enhanced VLDL-receptor expression following AMPK phosphoryla-
tion [8] may also contribute to increased lipid uptake, increasing
lipid accumulation into tissue less able to metabolise FA leading to
lipotoxicity [60].
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